Scarica l'app Stockscreener
37.55
2.61%
-1.006
Precedente Chiudi:
$38.56
Aprire:
$39.13
Volume 24 ore:
86,089
Relative Volume:
3.58
Capitalizzazione di mercato:
$N/A
Reddito:
-
Utile/perdita netta:
-
Rapporto P/E:
-
EPS:
-
Flusso di cassa netto:
-
1 W Prestazione:
-5.07%
1M Prestazione:
+6.36%
6M Prestazione:
+86.01%
1 anno Prestazione:
+54.51%
Intervallo 1D:
$37.30
$39.13
Intervallo di 1 settimana:
$37.30
$39.45
Portata 52W:
$13.42
$40.82
Virtus Lifesci Biotech Clinical Trials Etf Stock (BBC) Company Profile
Nome
Virtus Lifesci Biotech Clinical Trials Etf
Settore
Industria
Telefono
-
Indirizzo
-
Confronta BBC con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
BBC
Virtus Lifesci Biotech Clinical Trials Etf
|
37.47 | 0 | 0 | 0 | 0 | 0.00 |
|
VTI
Vanguard Total Stock Market Etf
|
336.46 | 417.53B | 0 | 0 | 0 | 0.00 |
|
SPY
Spdr S P 500 Etf Trust
|
683.36 | 372.57B | 0 | 0 | 0 | 0.00 |
|
IVV
Ishares Core S P 500 Etf
|
686.37 | 253.41B | 0 | 0 | 0 | 0.00 |
|
VB
Vanguard Small Cap Etf
|
261.88 | 160.59B | 0 | 0 | 0 | 0.00 |
|
QQQ
Invesco Qqq Trust Series 1
|
613.60 | 124.43B | 0 | 0 | 0 | 0.00 |
Virtus Lifesci Biotech Clinical Trials Etf Borsa (BBC) Ultime notizie
Biotech ETF (BBC) Hits New 52-Week High - MSN
(BBC) and the Role of Price-Sensitive Allocations - Stock Traders Daily
ETFs Investing in enGene Holdings Inc. Stocks - TradingView — Track All Markets
Virtus LifeSci Biotech Clinical Trials ETF declares annual distribution of $0.6554 - MSN
(BBC) Movement as an Input in Quant Signal Sets - Stock Traders Daily
Liquidity Mapping Around (BBC) Price Events - Stock Traders Daily
Why (BBC) Price Action Is Critical for Tactical Trading - Stock Traders Daily
Healthcare ETFs Trounce Tech, Grab Billions As Big Money Flees Bubble Fears - Sahm
The Zacks Analyst Blog Highlights LLY, EPHE, BBC, HELX, XHS and SURI - Yahoo Finance
Best-Performing ETFs of Last Week: Healthcare Rules - sharewise.com
Is Virtus LifeSci Biotech Clinical Trials stock ideal for retirement investors - newser.com
Is Virtus LifeSci Biotech Clinical Trials stock positioned for digital growth eraWeekly Trade Report & Low Risk Investment Opportunities - newser.com
Intellia Therapeutics: A Worst-Case Risk Becomes A Tragic Reality (Downgrade) - Seeking Alpha
Will Virtus LifeSci Biotech Clinical Trials stock profit from AI boom2025 Short Interest & Daily Profit Focused Screening - newser.com
Best-Performing ETFs of Last Week - sharewise.com
Understanding Momentum Shifts in (BBC) - news.stocktradersdaily.com
Avoiding Lag: Real-Time Signals in (BBC) Movement - news.stocktradersdaily.com
Virtus LifeSci Biotech Clinical Trials ETF (BBC) stock price, news, quote and history - Yahoo! Finance UK
Biotech ETFs Hovering Around a 52-Week: Here's Why - TradingView
Biotech ETFs Bounce Back in 2025: Here's Why - sharewise.com
Can Virtus LifeSci Biotech Clinical Trials stock deliver strong annual returns2025 Pullback Review & Fast Entry Momentum Alerts - nchmf.gov.vn
Discipline and Rules-Based Execution in BBC Response - news.stocktradersdaily.com
Trade War or Not, Specific Industry ETFs Are in Sweet Spots - TradingView
What MACD trends signal for Virtus LifeSci Biotech Clinical Trials stockWeekly Trade Review & Weekly Top Gainers Trade List - newser.com
Will Virtus LifeSci Biotech Clinical Trials stock return to pre crash levelsMarket Movers & Proven Capital Preservation Methods - newser.com
The Zacks Analyst Blog Highlights BWET, GOEX, SLVP, LIT and BBC - sharewise.com
Canadian Equities Shine: ETFs to Capture the Momentum - The Globe and Mail
2 High Risk ETFs That Aren’t Leveraged, Inverse, or Single-Stock - Investing.com
XBI: Surprise Exit Of A Tough Regulator At The FDA (NYSEARCA:XBI) - Seeking Alpha
(BBC) Technical Data - news.stocktradersdaily.com
How to Take Advantage of moves in (BBC) - news.stocktradersdaily.com
(BBC) Trading Report - news.stocktradersdaily.com
Vinay Prasad's Appointment To FDA's CBER Triggers Questions Over Future Of Cell And Gene Therapy Regulation - Benzinga
Tech Rally Boosted Wall Street Last Week: Winning ETFs in Focus - Nasdaq
6 Best-Performing ETFs of Last Week - Yahoo Finance
7 Best-Performing Biotech ETFs for March 2025 - NerdWallet
ETFis Series Trust IVirtus LifeSci Biotech Clinical Trials ETF announces Annual dividend, payable on December 29, 2025 - marketscreener.com
(BBC) Trading Signals - news.stocktradersdaily.com
TSLA-related ETFs among top performing ETFs on a 4-week performance base last week - Seeking Alpha
5 Top ETFs of Last Week - Yahoo Finance
SBIO, XBI, or BBP: Which is the Best Biotech ETF, According to Analysts? - Nasdaq
Pharma Stocks Look Cheap. Here's One Way to Invest. - Nasdaq
Virtus LifeSci Biotech Clinical Trials ETF (BBC) Stock Trends and Sentiment 2025 - MarketBeat
Long Term Trading Analysis for (BBC) - news.stocktradersdaily.com
The 5 Best Biotech ETFs of 2024 - ETF.com
Last Week, Virtus LifeSci Biotech Clinical Trials ETF Climbed 10%. Why? - CMC Markets
This biotech ETF sees ‘breakout’ while U.S. small-cap technology stocks lag - MarketWatch
ALPS’ Biotech ETF SBIO Week's Top Performer - ETF Trends
Virtus Lifesci Biotech Clinical Trials Etf Azioni (BBC) Dati Finanziari
Non sono disponibili dati finanziari per Virtus Lifesci Biotech Clinical Trials Etf (BBC). Controlla altri titoli per ulteriori informazioni.
Reddito
Reddito netto
Flusso di cassa
EPS
1.02%
0.41%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):